These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18843022)

  • 21. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
    Hu YY; Zheng R; Guo C; Niu YM
    Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis.
    Wang L; Wang Z; Gao X; Li X; Sun X; Liu C
    Tumour Biol; 2014 Feb; 35(2):1149-55. PubMed ID: 24186074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.
    Zhou C; An H; Hu M; Liu Q; Geng P; Xu J; Sun B; Liu C
    Tumour Biol; 2013 Dec; 34(6):3831-7. PubMed ID: 23873109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
    Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
    DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians.
    Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
    Cancer Invest; 2012 Nov; 30(9):630-6. PubMed ID: 23020291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
    Li J; Luo F; Zhang H; Li L; Xu Y
    Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.
    Forones NM; de Lima JM; de Souza LG; da Silva ID
    J Gastrointest Cancer; 2008; 39(1-4):118-23. PubMed ID: 19373442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a meta-analysis.
    Li M; Dai W; Zhou H
    ScientificWorldJournal; 2013; 2013():689048. PubMed ID: 24222746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between the G870A polymorphism of Cyclin D1 gene and glioma risk.
    Zong H; Cao L; Ma C; Zhao J; Ming X; Shang M; Xu H
    Tumour Biol; 2014 Aug; 35(8):8095-101. PubMed ID: 24840634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls.
    Zheng M; Wan L; He X; Qi X; Liu F; Zhang DH
    World J Surg Oncol; 2015 Feb; 13():55. PubMed ID: 25888980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis.
    Tang C; Wang Z; Yu J; Wu Y; Zhu Z; Chen N
    Med Oncol; 2011 Dec; 28(4):1319-24. PubMed ID: 20443083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.
    Sergentanis TN; Economopoulos KP
    Mol Biol Rep; 2011 Nov; 38(8):4955-63. PubMed ID: 21161398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.
    Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X
    Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
    Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
    Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
    Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.
    Zhang LQ; Huang XE; Wang J; Shang JQ; Bai J; Liu FY; Guan X; Zhou JN
    Asian Pac J Cancer Prev; 2011; 12(1):81-5. PubMed ID: 21517236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of cyclin D1 variants with head and neck cancer susceptibility: evidence from a meta-analysis.
    Lin H; Fang L; Lin D
    Asian Pac J Cancer Prev; 2014; 15(14):5645-51. PubMed ID: 25081680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
    Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
    Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
    Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.